Evidence map›Paper›PMID 36646508›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Porphyrins-Assisted Cocatalyst Engineering with CoOV Bond in BiVO

Linxing Meng, Zunyan Lv, Weiwei Xu, Wei Tian, Liang Li

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 47 citations in OpenAlex.

  1. Dual Mo-Doping in BiVOAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  2. Porphyrins-Assisted Cocatalyst Engineering with CoOV Bond in BiVOAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Linxing MengSchool of Physical Science and Technology, Jiangsu Key Laboratory of Thin Films, Center for Energy Conversion Materials and Physics (CECMP), Soochow University, Suzhou, 215006, P. R. China.
Zunyan LvSchool of Physical Science and Technology, Jiangsu Key Laboratory of Thin Films, Center for Energy Conversion Materials and Physics (CECMP), Soochow University, Suzhou, 215006, P. R. China.
Weiwei XuSchool of Physical Science and Technology, Jiangsu Key Laboratory of Thin Films, Center for Energy Conversion Materials and Physics (CECMP), Soochow University, Suzhou, 215006, P. R. China.
Wei TianSchool of Physical Science and Technology, Jiangsu Key Laboratory of Thin Films, Center for Energy Conversion Materials and Physics (CECMP), Soochow University, Suzhou, 215006, P. R. China.
Liang LiSchool of Physical Science and Technology, Jiangsu Key Laboratory of Thin Films, Center for Energy Conversion Materials and Physics (CECMP), Soochow University, Suzhou, 215006, P. R. China.ORCID https://orcid.org/0000-0003-0708-7762
Soochow University · CN

Funding

National Key Research and Development Program of China 2021YFA1500800National Natural Science Foundation of China 52025028National Natural Science Foundation of China 52202272
6 · The paper itself

Abstract

The application of photoelectrochemical (PEC) water splitting is limited by the sluggish surface oxygen evolution reaction (OER) kinetics. OER kinetics can be effectively improved through cocatalyst engineering. However, the tardy transfer process and serious recombination of carriers are the key factors restricting the cocatalyst development. Taking BiVO

Indexed as

BiVO4cocatalystsphotoanodewater splitting

Identifiers

PMID36646508
PMCPMC10015896
OpenAlexW4316653735

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read49
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.